Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Up to 25% of patients with profound neutropenia lasting for >10 days develop lung infiltrates, which frequently do not respond to broad-spectrum antibacterial therapy. While a causative pathogen remains undetected in the majority of cases, Aspergillus spp., Pneumocystis jirovecii, multi-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Maschmeyer, G., Carratalà, J., Buchheidt, D., Hamprecht, A., Heussel, C.P., Kahl, C., Lorenz, J., Neumann, S., Rieger, C., Ruhnke, M., Salwender, H., Schmidt-Hieber, M., Azoulay, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: THE AUTHORS. Published by Elsevier Ltd. 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269340/
https://www.ncbi.nlm.nih.gov/pubmed/24833776
http://dx.doi.org/10.1093/annonc/mdu192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269340/
https://www.ncbi.nlm.nih.gov/pubmed/24833776
http://dx.doi.org/10.1093/annonc/mdu192

Ejemplares similares